Nutritional support for children with solid tumors
Part of Cancer clinical trials.
This trial studies whether a standardized nutrition plan helps children with newly diagnosed solid tumors. It aims to improve treatment outcomes through better nutrition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child between 0 and 18 years old
- You have been newly diagnosed with a solid tumor that hasn't been treated yet
- The diagnosis is confirmed by a biopsy or pathology test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called TH027 for people with certain advanced solid tumors (osteosarcoma, neuroblastoma, gastric cancer, or lung cancer) that have not responded to standard therapies. TH027 targets a protein called CD276 on cancer cells, which may help your immune system fight the tumor.
This trial uses lab-grown tumor samples from your child to test which chemotherapy drugs work best for their specific cancer. The goal is to find the most effective treatment by testing medicines on their tumor cells before giving them to your child.
This trial analyzes the tumor environment in children with solid tumors to find better ways to use immune cells for treatment. It may help develop new cell-based therapies tailored to each child's tumor.
This trial tests a combination of four drugs (liposomal irinotecan, vincristine, temozolomide, and anlotinib) for children and teens whose solid tumors have come back or haven't responded to standard treatment. The goal is to see if this drug mix can shrink or control the tumors.
This trial tests a combination of three chemotherapy drugs (irinotecan, temozolomide, and vincristine) in children and teens whose solid tumors have come back or stopped responding to standard treatment. The goal is to see if this combination can help shrink or control the tumors.
This trial offers access to experimental or non-standard cancer treatments for people with advanced solid tumors who have run out of standard options. The goal is to find new ways to treat cancers that are hard to manage.
Hear when a new Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.